Daud, Fari Ananda and Ratnawati, Hana (2021) Overview of Anosmia Symptoms in Covid-19 Patients. In: International Webinar Covid-19 Pandemic: Impacts, Strategies, and Challenges on the Urban Health, 3-4 September 2021.
|
Text
Oral Presentation_Overview of Anosmia Symptoms in Covid-19 Patients_International Webinar.pdf Download (1514Kb) | Preview |
Abstract
Introduction: It's been more than a year since Covid-19 was declared as a pandemic in March 2020, but until now there are still many new things. Covid-19 is usually described with typical symptoms of fever, cough, myalgia and fatigue, known as flu-like symptoms, but it turns out that other clinical manifestations such as anosmia and dysgeusia was recognized as an important symptoms of COVID-19. The purpose of this study was to review the anosmia symptoms in Covid-19 patients. Methods: This is a retrospective study using medical record data from the outpatient ENT clinic of RSUD Sumedang, in January-February 2021. Qualitative anosmia test using the ODoR-19 scale, with 3 sources of odor, which are eucalyptus oil, alcohol and peppermint. A value of 0 indicates anosmia and a value of 10 is normal. Result: The results showed that there were 68 Covid-19 patients consisting of 43 women (63.2%) and 25 men (36.8%) with ages between 13-81 years and mean 48.31±16.09 years. Anosmia was found in 24 patients (35.5%) and only 3 patients accompany with dysgeusia. The mean age of patients with anosmia was 41.04±15.87 years while those without anosmia was 52.27±14.94 years and significantly different (p=0.005). Anosmia was more common in individu younger than 60 years (43.40%) compared to individu more than 60 years (6.67%). Anosmia found in 70.8% women compared to group without anosmia, there was 59.10% women. The initial onset of anosmia was on day 3 and no later than day 9 since the first symptoms with a mean of 4.83±1.90 days. In addition to anosmia, all patients were accompanied by fever (100%), cough (62.5%), and headache (29.2%). The qualitative anosmia test showed, respectively, 2.78% mild anosmia, 11.11% moderate anosmia and 86.11% severe anosmia. What is interesting about this study is that dyspnea was much more common in patients without anosmia (75%) compared to patients with anosmia (20.8%). Conclusion: Anosmia was found in 35.5% of Covid-19 patients and only 12.5% were accompanied by dysgeusia. Anosmia was more common in women (70.8%) and individu younger than 60 years (43.40%) compared to individu older than 60 years (6.67%) The initial onset of anosmia was on the third day and all accompanied by fever. Qualitative anosmia examination using the ODoR-19 scale, showed 86.11% had severe anosmia.
| Item Type: | Conference or Workshop Item (Paper) |
|---|---|
| Uncontrolled Keywords: | anosmia, Covid-19 |
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Perpustakaan Maranatha |
| Date Deposited: | 15 Mar 2022 10:01 |
| Last Modified: | 15 Mar 2022 10:03 |
| URI: | http://repository.maranatha.edu/id/eprint/30149 |
Actions (login required)
 |
View Item |
